Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,135.95
(
-0.04%
)
US TECH 100
26,604.40
(
0.54%
)
Dow Jones
48,861.81
(
0.00%
)
Brent Oil
108.57
(
-3.39%
)
Bitcoin
76,328.96
(
0.73%
)
News Focus
News Focus
Post# of 257470
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122909
Boards Moderated 9
Alias Born 09/05/2002

DewDiligence

Member Level

Re: DewDiligence post# 248713

Tuesday, 04/15/2025 11:33:47 AM

Tuesday, April 15, 2025 11:33:47 AM

Post# of 257470
Biocon’s Eylea biosimilar will launch in US market in 2H26, pursuant to litigation settlement with REGN:

https://www.prnewswire.com/news-releases/biocon-biologics-secures-market-entry-date-for-yesafili-an-interchangeable-biosimilar-to-eylea-in-the-us-302428884.html

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today